Copyright
©The Author(s) 2015.
World J Stem Cells. May 26, 2015; 7(4): 776-788
Published online May 26, 2015. doi: 10.4252/wjsc.v7.i4.776
Published online May 26, 2015. doi: 10.4252/wjsc.v7.i4.776
Figure 5 In vivo homing and engraftment of administered fetal kidney stem cells in renal tubules.
Representative immunofluorescent photomicrographs (Scale bars indicate 20 μm) showing engraftment of administered fetal kidney stem cells (fKSC) in renal tubules at day 7 of therapy, and expression of tubular epithelial and endothelial markers aquaporin (AQP)1 (A) and Von Willebrand factor (vWF) (B) respectively, with corresponding Hoechst, PKH26 labeled administered fKSC in injured kidney tissue respectively.
- Citation: Gupta AK, Jadhav SH, Tripathy NK, Nityanand S. Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J Stem Cells 2015; 7(4): 776-788
- URL: https://www.wjgnet.com/1948-0210/full/v7/i4/776.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i4.776